Pivot3 to Acquire NexGen Storage to Shift the Hyper-Converged Market toward More Dynamic Solutions
27.1.2016 12:00 | Business Wire
Pivot3, a pioneer and innovator in the development of hyper-converged infrastructure (HCI), today announced that it will acquire NexGen Storage, a privately held leading provider of hybrid storage appliances, dynamic all-flash arrays and Quality of Service (QoS) capabilities. By adding NexGen’s portfolio of products, Pivot3 will deliver the industry's most complete set of dynamic hyper-converged solutions. For the first time ever, enterprise and mid-market companies will have access to a suite of solutions that will allow them to apply the right infrastructure and priority to each workload, application or business service according to business value.
By adding NexGen’s strengths in accelerated all-flash and hybrid storage, Pivot3 is uniquely expanding the traditional notion of hyper-convergence. Now, customers have complete implementation flexibility and QoS management, so IT no longer has to overprovision for peak workloads, but instead can use just-in-time dynamic provisioning of resources and scale as the business grows. Pivot3 intends to market and enhance all current and planned NexGen products.
“Everyone talks about the need for agility in terms of business needs, but in hyper-convergence, workload utilization and performance have been gating factors to expansion beyond the usual initial use cases,” said Ron Nash, CEO of Pivot3. “With the addition of NexGen’s capabilities, Pivot3 is now the only company in the market that broadly and deeply addresses this central data center challenge with a solution that allows IT to prioritize application performance based on business priority. We believe this agility is critical as customers move from legacy data centers to a software-defined data center that effortlessly handles a heterogeneous set of workloads. We welcome the NexGen customers, partners and team to Pivot3.”
Unlike other storage arrays and hyper-converged systems that treat all data the same, NexGen’s dynamic QoS governs performance targets, input/output (I/O) prioritization and data placement, allowing customers to meet business service-level agreements. For example, an organization serving the healthcare market can prioritize mission-critical hospital system applications over the internal Microsoft Exchange server, preventing a surge in employee email downloads from interrupting life-or-death health care system operations.
“We categorize all of our applications as mission-critical, business-critical or non-critical,” said Michael Frank, manager IT services group, NCS Credit. “We need our systems to be able to recognize that not all applications are created equal and to process them appropriately and differentially.”
“Not all data should be treated the same; the growing momentum of the Internet of Things (IoT), together with ever-increasing user-expectations and application-demands, means there is a pressing need for HCI platforms that are optimally built to manage the onslaught of disparate data,” said Mark Peters, practice director and senior analyst at Enterprise Strategy Group (ESG). “Pivot3’s new approach offers precisely this with its hyper-converged solution-suite; it includes compelling differentiations which enable it to support more extensive and expansive use cases by delivering increased and optimized value from the data it manages.”
Dynamic hyper-convergence provides enterprises with a practical and proven path to extend the economics and simplicity of HCI to all business services, effectively enabling the first generation of software-defined data centers. Pivot3 provides HCI, hybrid and all-flash storage in appliance and blade form factors. Their patented Scalar Erasure Coding gives their HCI technology the ability to yield up to 94 percent usable storage, and their all-flash HCI appliances are specifically designed to provide maximum input/output operations per second (IOPS) for high-performance applications. Combined with NexGen’s proven QoS and dynamic provisioning capabilities, high-performance hybrid storage and all-flash form factors, Pivot3 now provides the most extensive suite of HCI solutions available in the market.
“We’re proud of our rich history and our reputation as a leader in new technology storage products, and we see enormous synergies in bringing together these two innovative businesses,” said John Spiers, founder and CEO of NexGen. “The pedigrees of our teams in the storage and high-performance computing markets are unparalleled in the industry. Combining these powerful teams and innovative solutions gives our customers and partners an incredible advantage in their respective markets.”
Pivot3 executed a definitive agreement to acquire NexGen following the unanimous approval of the Boards of Directors of Pivot3 and NexGen. The transaction is expected to close in February 2016.
Pivot3 is the world’s leading provider of dynamic hyper-converged solutions. Pivot3’s patented solutions dramatically improve data center simplicity and economics by increasing scale-out performance, driving down complexity and cost, saving an extraordinary amount of disk and physical space and ensuring fault tolerance. With Pivot3’s unique Quality of Service and Virtualization Management capabilities, customers are able to prioritize data and application performance based on business value. Today, Pivot3 has more than 2,000 customers around the world deploying more than 16,000 globally hyper-converged infrastructures in multiple industries such as video surveillance, healthcare, government, transportation, entertainment, education, gaming and retail. Join us on LinkedIn, follow us on Facebook or Twitter (@Pivot3Inc) or visit us at http://pivot3.com. The company has won numerous awards and was most recently featured by CRN in their top 50 Virtualization list. To learn more about Pivot3, visit http://www.pivot3.com.
Allison Francis, 972-235-3439
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15 | Pressemelding
Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11 | Pressemelding
Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy
European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25 | Pressemelding
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the
IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00 | Pressemelding
IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman
PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03 | Pressemelding
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate
Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00 | Pressemelding
Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom